Drug Farm today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to DF-003, the company's investigational small molecule inhibitor targeting ALPK1, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results